You have access
Impact of Relative Dose Intensity of Early-phase Lenvatinib Treatment on Therapeutic Response in Hepatocellular Carcinoma
AYA TAKAHASHI, MICHIHISA MORIGUCHI, YUYA SEKO, HIROKI ISHIKAWA, TAKAHARU YO, HIROYUKI KIMURA, HIDEKI FUJII, TOSHIHIDE SHIMA, YASUHIDE MITSUMOTO, HIROSHI ISHIBA, HIDETAKA TAKASHIMA, YASUYUKI NAGAO, MASAYASU JO, MASAHIRO ARAI, TASUKU HARA, AKIRA OKAJIMA, AKIRA MURAMATSU, ATSUHIRO MORITA, NAOMI YOSHINAMI, TOMOKI NAKAJIMA, HIRONORI MITSUYOSHI, ATSUSHI UMEMURA, TAICHIRO NISHIKAWA, KANJI YAMAGUCHI and YOSHITO ITOH
Anticancer Research September 2019, 39 (9) 5149-5156; DOI: https://doi.org/10.21873/anticanres.13710